JAC Advance Access originally published online on January 14, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2003) 51, 415-418
© 2003 The British Society for Antimicrobial Chemotherapy
Occurrence and detection of AmpC ß-lactamases among Gram-negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur Hospital, Delhi, India
Department of Microbiology, University College of Medical Sciences and Guru Tegh Bahadur Hospital, Dilshad Garden, 110095 Delhi, India
Received 1 July 2002; returned 2 August 2002; revised 11 November 2002; accepted 20 November 2002
AmpC enzymes can be differentiated from other extended-spectrum ß-lactamases by their ability to hydrolyse cephamycins as well as other extended-spectrum cephalosporins. The present study was designed to determine the occurrence of AmpC enzyme-harbouring Gram-negative clinical isolates in a tertiary care hospital in Delhi, India. Among the 135 clinical isolates of Gram-negative bacilli tested, 20.7% were found to harbour AmpC enzymes using a modified three-dimensional test. Inhibition of zone distortion in the presence of cloxacillin confirmed AmpC-harbouring isolates. Maximal incidence of AmpC producers was found among Acinetobacter spp. (42.8%) followed by Klebsiella pneumoniae isolates (33.3%). No AmpC-harbouring isolates revealed decreased susceptibility to cefoxitin. Therefore, Gram-negative bacilli showing resistance to any cephalosporin or aztreonam irrespective of cefoxitin susceptibility should be screened for the AmpC enzyme. The modified three-dimensional test is easy to carry out and can be applied as a phenotypic screening method for detection of AmpC-harbouring Gram-negative organisms. This is the first study to determine the occurrence of AmpC ß-lactamases from India.
Keywords: AmpC ß-lactamases, ESBLs, three-dimensional technique, AmpC India
* Corresponding author. Tel: +91-11-2747-2222; Fax: +91-11-2229-0495; E-mail: manchandavikas{at}hotmail.com
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. A. Jacoby AmpC {beta}-Lactamases Clin. Microbiol. Rev., January 1, 2009; 22(1): 161 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-X. Zhu, Z.-W. Zhang, D. Liang, D. Jiang, C. Wang, N. Du, Q. Zhang, K. Mitchelson, and J. Cheng Multiplex Asymmetric PCR-Based Oligonucleotide Microarray for Detection of Drug Resistance Genes Containing Single Mutations in Enterobacteriaceae Antimicrob. Agents Chemother., October 1, 2007; 51(10): 3707 - 3713. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ruppe, P. Bidet, C. Verdet, G. Arlet, and E. Bingen First Detection of the Ambler Class C 1 AmpC {beta}-Lactamase in Citrobacter freundii by a New, Simple Double-Disk Synergy Test J. Clin. Microbiol., November 1, 2006; 44(11): 4204 - 4207. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-X. Chen, R. Zhang, and H. W. Zhou Heterogeneity of metallo-{beta}-lactamases in clinical isolates of Chryseobacterium meningosepticum from Hangzhou, China J. Antimicrob. Chemother., April 1, 2006; 57(4): 750 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Black, K. S. Thomson, J. D. Buynak, and J. D. D. Pitout Evaluation of {beta}-Lactamase Inhibitors in Disk Tests for Detection of Plasmid-Mediated AmpC {beta}-Lactamases in Well-Characterized Clinical Strains of Klebsiella spp. J. Clin. Microbiol., August 1, 2005; 43(8): 4168 - 4171. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Black, E. S. Moland, and K. S. Thomson AmpC Disk Test for Detection of Plasmid-Mediated AmpC {beta}-Lactamases in Enterobacteriaceae Lacking Chromosomal AmpC {beta}-Lactamases J. Clin. Microbiol., July 1, 2005; 43(7): 3110 - 3113. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yagi, J.-i. Wachino, H. Kurokawa, S. Suzuki, K. Yamane, Y. Doi, N. Shibata, H. Kato, K. Shibayama, and Y. Arakawa Practical Methods Using Boronic Acid Compounds for Identification of Class C {beta}-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli J. Clin. Microbiol., June 1, 2005; 43(6): 2551 - 2558. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-J. Yan, W.-C. Ko, H.-M. Wu, S.-H. Tsai, C.-L. Chuang, and J.-J. Wu Complexity of Klebsiella pneumoniae Isolates Resistant to Both Cephamycins and Extended-Spectrum Cephalosporins at a Teaching Hospital in Taiwan J. Clin. Microbiol., November 1, 2004; 42(11): 5337 - 5340. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nasim, S. Elsayed, J. D. D. Pitout, J. Conly, D. L. Church, and D. B. Gregson New Method for Laboratory Detection of AmpC {beta}-Lactamases in Escherichia coli and Klebsiella pneumoniae J. Clin. Microbiol., October 1, 2004; 42(10): 4799 - 4802. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shahid, A. Malik, M. Agrawal, and S. Singhal Phenotypic detection of extended-spectrum and AmpC {beta}-lactamases by a new spot-inoculation method and modified three-dimensional extract test: comparison with the conventional three-dimensional extract test J. Antimicrob. Chemother., September 1, 2004; 54(3): 684 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Black, K. S. Thomson, and J. D. D. Pitout Use of {beta}-Lactamase Inhibitors in Disk Tests To Detect Plasmid-Mediated AmpC {beta}-Lactamases J. Clin. Microbiol., May 1, 2004; 42(5): 2203 - 2206. [Abstract] [Full Text] [PDF] |
||||



